AK Oglesby

633 total citations
11 papers, 455 citations indexed

About

AK Oglesby is a scholar working on Rheumatology, Ophthalmology and Epidemiology. According to data from OpenAlex, AK Oglesby has authored 11 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Rheumatology, 2 papers in Ophthalmology and 2 papers in Epidemiology. Recurrent topics in AK Oglesby's work include Systemic Lupus Erythematosus Research (3 papers), Retinal Imaging and Analysis (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). AK Oglesby is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Retinal Imaging and Analysis (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). AK Oglesby collaborates with scholars based in United States, Sweden and Netherlands. AK Oglesby's co-authors include B Jönsson, Olof Johnell, J. A. Kanis, Anders Odén, Chris De Laet, Kristina Secnik, Matthew D. Rousculp, Mark Kosinski, Anju Parthan and Gregory Lenhart and has published in prestigious journals such as Bone and Value in Health.

In The Last Decade

AK Oglesby

11 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AK Oglesby United States 3 321 296 102 70 57 11 455
Hyun-Koo Yoon South Korea 5 224 0.7× 236 0.8× 58 0.6× 47 0.7× 32 0.6× 5 389
Natalia Crespí Villarías Spain 5 144 0.4× 238 0.8× 46 0.5× 101 1.4× 29 0.5× 7 367
Andrew D. Bunta United States 14 476 1.5× 384 1.3× 185 1.8× 33 0.5× 52 0.9× 16 633
Merih Sarıdoğan Türkiye 5 150 0.5× 108 0.4× 39 0.4× 22 0.3× 28 0.5× 15 290
Pamela Morin United States 8 110 0.3× 88 0.3× 28 0.3× 19 0.3× 19 0.3× 13 257
Takeshi Horii Japan 10 67 0.2× 130 0.4× 31 0.3× 29 0.4× 48 0.8× 40 345
O. Guzón Illescas Spain 4 152 0.5× 246 0.8× 50 0.5× 105 1.5× 31 0.5× 6 357
David L. Boardman United States 9 233 0.7× 247 0.8× 136 1.3× 6 0.1× 19 0.3× 13 423
A. Torrijos Spain 11 285 0.9× 65 0.2× 143 1.4× 14 0.2× 67 1.2× 17 453
Marina Peña Spain 3 140 0.4× 232 0.8× 43 0.4× 102 1.5× 30 0.5× 3 326

Countries citing papers authored by AK Oglesby

Since Specialization
Citations

This map shows the geographic impact of AK Oglesby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AK Oglesby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AK Oglesby more than expected).

Fields of papers citing papers by AK Oglesby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AK Oglesby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AK Oglesby. The network helps show where AK Oglesby may publish in the future.

Co-authorship network of co-authors of AK Oglesby

This figure shows the co-authorship network connecting the top 25 collaborators of AK Oglesby. A scholar is included among the top collaborators of AK Oglesby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AK Oglesby. AK Oglesby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Priest, Julie, et al.. (2018). Benchmarking HIV Quality Measures Across US Payer Types. Value in Health. 21. S159–S159. 1 indexed citations
2.
Oglesby, AK, Emily Durden, S Narayanan, Paul Juneau, & Kathleen Wilson. (2013). Economic burden of systemic lupus erythematosus (SLE) in a commercially insured population in the United States. Value in Health. 16(3). A126–A126. 2 indexed citations
3.
Arondekar, Bhakti, Suellen M. Curkendall, Matthew Monberg, et al.. (2013). Economic Burden Associated With Adverse Events In Patients With Metastatic Melanoma. Value in Health. 16(3). A137–A137. 1 indexed citations
4.
Jolly, Meenakshi, Mark Kosinski, Cindy Garris, & AK Oglesby. (2012). PSY39 Validation of the Lupus Impact Tracker (LIT), a Patient-Reported Outcome (PRO) Tool, in a Prospective Multicenter Longitudinal Study of Systemic Lupus Erythematosus (SLE) Patients. Value in Health. 15(7). A515–A515. 1 indexed citations
5.
Oglesby, AK, G. Dennis, Caroline Korves, et al.. (2012). PSY56 Impact of Early Versus Late Systemic Lupus Erythematosus (SLE) Diagnosis on Clinical and Economic Outcomes. Value in Health. 15(4). A109–A109. 1 indexed citations
6.
Parthan, Anju, et al.. (2010). PCN45 HEALTH CARE RESOURCE UTILIZATION (HRU) IN ADVANCED OVARIAN CANCER-FINDINGS FROM LINKED SEER-MEDICARE DATA. Value in Health. 13(3). A31–A31. 1 indexed citations
7.
Rousculp, Matthew D., et al.. (2007). PDB33 VALIDATION OF THE 25-ITEM NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE (VFQ-25) IN PATIENTS WITH DIABETIC RETINOPATHY. Value in Health. 10(3). A69–A70. 3 indexed citations
8.
9.
Oglesby, AK, et al.. (2005). PDB16 THE ASSOCIATION BETWEEN DIABETES RELATED MEDICAL COSTS AND GLYCEMIC CONTROL: A LONGITUDINAL ANALYSIS. Value in Health. 8(3). 356–357. 4 indexed citations
10.
Secnik, Kristina, et al.. (2005). PDB5 IMPROVED TREATMENT SATISFACTION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE OR INSULIN GLARGINE. Value in Health. 8(6). A155–A156. 1 indexed citations
11.
Kanis, J. A., Anders Odén, Olof Johnell, et al.. (2003). The components of excess mortality after hip fracture. Bone. 32(5). 468–473. 439 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyun-Koo Yoon Breakdown of academic impact, for papers by Natalia Crespí Villarías Breakdown of academic impact, for papers by Andrew D. Bunta Breakdown of academic impact, for papers by Merih Sarıdoğan Breakdown of academic impact, for papers by Pamela Morin Breakdown of academic impact, for papers by Takeshi Horii Breakdown of academic impact, for papers by O. Guzón Illescas Breakdown of academic impact, for papers by David L. Boardman Breakdown of academic impact, for papers by A. Torrijos Breakdown of academic impact, for papers by Marina Peña
Rankless by CCL
2026